We are live on ! Find out more
PLD icon

PROLOGIS

Delisted

PLD was delisted on the 2nd of June, 2011.

2 hedge funds and large institutions have $702K invested in PROLOGIS in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

32% more capital inflows, than outflows

Capital inflows: $102K | Capital outflows: $77.4K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WOC
West Oak Capital
California
+$102K

Top Sellers

Rank Fund Capital Flow
1
BEAM
Baker Ellis Asset Management
Washington
-$77.4K

PLD Hedge Fund Activity: Q4 2017 in Review

2 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in PROLOGIS (PLD) for Q4 2017, worth a combined $702K — up 5.4% from $666K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PLD positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was West Oak Capital, opening a new position worth an estimated $102K. The largest seller was Baker Ellis Asset Management, cutting an estimated $77.4K.

  • 2 institutional investors held PROLOGIS (PLD) as of Q4 2017, up from 1 in Q3 2017.
  • Funds reported $702K of PROLOGIS stock for Q4 2017, up 5.4% quarter-over-quarter.
  • 1 fund opened new PROLOGIS positions in Q4 2017 and 0 closed out, a net change of +1 holder.
  • The largest PROLOGIS buyer in Q4 2017 was West Oak Capital, an estimated $102K added.
  • The largest PROLOGIS seller in Q4 2017 was Baker Ellis Asset Management, an estimated $77.4K sold.

Based on aggregated 13F filings for Q4 2017.